期刊文献+

利伐沙班联合支架植入术治疗下肢动脉硬化闭塞症的疗效及对患者血管内皮功能、血流动力学指标的影响 被引量:1

Therapeutic effect of rivaroxaban combined with stent implantation in the treatment of lower limb arteriosclerosis obliterans and its impact on vascular endothelial function and hemodynamic indicators in patients
下载PDF
导出
摘要 目的探讨利伐沙班联合支架植入术治疗下肢动脉硬化闭塞症的临床效果,并分析其对患者血管内皮功能、血流动力学指标的影响。方法选取2021年9月至2023年4月青岛大学附属医院收治的108例下肢动脉硬化闭塞症患者,在组间基线特征可比的原则上,随机分为观察组和对照组,每组54例。对照组采取支架置入术进行治疗,术后口服拜阿司匹灵(100 mg/d),观察组在此基础上术后联合利伐沙班(5 mg/d)治疗。比较两组的临床疗效,治疗前和治疗1个月后血管内皮功能指标[硝酸甘油介导的非内皮依赖性舒张功能(NMD)、血流介导的血管扩张功能(FMD)、一氧化氮(NO)、内皮素(ET)]及血流动力学指标(足背动脉内径、血流量和血流速度峰值)的变化,以及术后并发症发生情况。结果观察组治疗总有效率(90.74%)明显高于对照组(75.93%),差异有统计学意义(P<0.05)。治疗前两组NMD、FMD、NO、ET水平比较差异无统计学意义(P>0.05);治疗1个月后两组患者的NMD、FMD、NO水平明显高于治疗前,且观察组高于对照组,而ET水平明显低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。治疗前两组足背动脉内径、血流量和血流速度峰值比较差异无统计学意义(P>0.05);治疗1个月后两组足背动脉内径及血流量明显高于治疗前,且观察组高于对照组,而血流速度峰值明显低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。观察组术后并发症总发生率为5.56%,明显低于对照组的20.37%,差异有统计学意义(P<0.05)。结论利伐沙班联合支架植入可提高下肢动脉硬化闭塞症的治疗效果,并能显著改善患者的血管内皮功能及血流动力学指标,减少术后并发症的发生,值得临床应用。 Objective To explore the efficacy of rivaroxaban combined with stent implantation in the treatment of lower limb arteriosclerosis obliterans,and to observe and analyze the impact of combined treatment on vascular endothelial function and hemodynamic indicators in patients.Method One hundred and eight patients with lower limb arteriosclerosis obliterans admitted to our hospital from September 2021 to April 2023 were selected as the research subjects and randomly divided into an observation group and a control group,with 54 patients in each group.Both groups of patients underwent stent implantation for treatment,and received oral administration of baiaspirin(100 mg/d)after the surgery,while the observation group received postoperative treatment in combination with rivaroxaban(5 mg/d).Compare the clinical efficacy of treatment between two groups of patients;Observe the changes in vascular endothelial function and hemodynamic indicators before and after 1 month of treatment in both groups of patients,and the occurrence of postoperative complications.Result The total effective rate of treatment in the observation group was significantly higher than that in the control group(90.74%vs 75.93%,χ2=4.2667,P=0.0389).After treatment,the nitroglycerin-mediated dilation(NMD),flow-mediated dilation(FMD)and nitric oxide(NO)level in both groups significantly increased,and the observation group showed a more significant increase compared to the control group(P<0.05).The endothelin(ET)levels in both groups were significantly reduced compared to before treatment,and the observed group showed a more significant decrease compared to the control group(P<0.05).After treatment,the inner diameter and bloodflow of the dorsalis pedis artery in both groups of patients significantly increased,and the observation group showed a more significant increase compared to the control group(P<0.05).The peak blood flow velocity significantly decreased,and the observation group showed a more significant decrease compared to the control group(P<0.05).The total incidence of complications in the postoperative observation group was significantly lower than that in the control group(5.56%vs 20.37%,χ2=5.2523,P=0.0219).Conclusion The combination of Levofloxacin and stent implantation can improve the clinical efficacy of treating lower limb arteriosclerosis obliterans,significantly improve vascular endothelial function and hemodynamic indicators in patients,and help reduce the incidence of complications.It is worthy of clinical promotion and application.
作者 曲泓宇 李永欣 郭明金 Qu Hongyu;Li Yongxin;Guo Mingjin(Graduate School of Qingdao University,Qingdao Shandong 266100,China;Department of Vascular Surgery,Affiliated Hospital of Qingdao University,Qingdao Shandong 266555,China)
出处 《中国医刊》 CAS 2024年第3期280-283,共4页 Chinese Journal of Medicine
基金 山东省自然科学基金面上项目(ZR2022MH031)。
关键词 利伐沙班 支架植入术 下肢动脉硬化闭塞症 血管内皮功能 血流动力学 Rivaroxaban Stent implantation Lower limb arteriosclerosis obliterans Vascular endothelial function Hemodynamic
  • 相关文献

参考文献21

二级参考文献244

  • 1谷新胜,何悦,赵莉芳,陈小妮,高迪,郑宏超.利伐沙班治疗心房颤动合并稳定性冠心病的临床疗效观察[J].实用心脑肺血管病杂志,2020(S02):117-119. 被引量:3
  • 2李龙学.内皮素-1和C-反应蛋白对急性肺栓塞病情和预后的评估[J].医学临床研究,2012,29(6). 被引量:4
  • 3L. Norgren,W.R. Hiatt,J.A. Dormandy,M.R. Nehler,K.A. Harris,F.G.R. Fowkes.Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)[J]. Journal of Vascular Surgery . 2007 (1)
  • 4Florian Dick,Nicolas Diehm,Aekaterini Galimanis,Marc Husmann,Juerg Schmidli,Iris Baumgartner.Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome[J].Journal of Vascular Surgery.2007(4)
  • 5BessFowler,KonradJamrozik,PaulNorman,YvonneAllen.Prevalence of peripheral arterial disease: persistence of excess risk in former smokers[J].Australian and New Zealand Journal of Public Health.2007(3)
  • 6Pennywell DJ,Tan TW,Zhang WW.Optimal management of infrainguinal arterial occlusive disease.Vasc Health Risk Manag,2014,10:599-608.
  • 7Morgan MB,Crayford T,Murrin B,et al.Developing the vascular quality of life questionnaire:a new disease-specific quality of life measure for use in lower limb ischemia.J Vasc Surg,2001,33:679-687.
  • 8Liles DR,Kallen MA,Petersen LA,et al.Quality of life and peripheral arterial disease.J Surg Res,2006,136:294-301.
  • 9Vlajinac H,Marinkovic J,Tanaskovic S,et al.Quality of life after peripheral bypass surgery:a 1year follow-up.Wien Klin Wochenschr,2015,127:210-217.
  • 10Dreyer RP,van Zitteren M,Beltrame JF,et al.Gender differences in health status and adverse outcomes among patients with peripheral arterial disease.J Am Heart Assoc,2014,4:e000863.

共引文献523

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部